A unique monoclonal protein, Pritoxaximab – formerly known as DXX00601 – shows considerable promise for the treatment of critical immune condition (TRALI). Engineered by Bio-X, Pritoxaximab functions by blocking https://pritoxaximab-liquid-form235317.blognody.com/profile